Chief Commercial Officer · Kalaris Therapeutics, Inc. (KLRS)

Jeroen van Beek

FY2021 is the first fiscal year CompBrief holds for Jeroen van Beek as a named executive officer of Kalaris Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$4,172,849

Salary $425,000Stock awards $1,475,250

5th of 5 named executive officers at Kalaris Therapeutics by FY2021 total.

5 named officers on file for Kalaris Therapeutics, FY2021

Jeroen van Beek’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Kalaris Therapeutics’s whole pay program stands against its peers

  • Kalaris Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on KLRS→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 6, 2022 (DEF 14A).

Free

Get Jeroen van Beek’s full pay file as a PDF — free

More than this page: up to 10 years of Jeroen’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Jeroen van Beek compensation by year

Kalaris Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as Kalaris Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$425,000
Bonus$0
Stock awards$1,475,250
Option awards$2,096,599
Non-equity incentive$170,000
Pension and deferred compensation$0
All other$6,000
Total$4,172,849

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Kalaris Therapeutics, Inc. DEF 14A filed April 6, 2022, accession 0001193125-22-097515, and prior-year filings.

How this page was built: the Kalaris Therapeutics, Inc. filed document, accession 0001193125-22-097515. Every figure is read from that document and cited to the page and table it appears in. Filed April 6, 2022.

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU124,536$1,611,496—
RSU35,000$452,900—
RSU6,291$81,406—
Option65,000—$42.15
Option163,075—$17.00

Per the Outstanding Equity Awards at Fiscal Year-End table in Kalaris Therapeutics, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Kalaris Therapeutics’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
David HallalChairman and Former Chief Executive Office r$16,797,713
Diana BrainardChief Executive Officer$15,136,121
Vikas SinhaPresident and Chief Financial Officer$6,622,996
Agustin MelianFormer Chief Medical Officer$5,830,095
Jeroen van Beek · this pageChief Commercial Officer$4,172,849

The full Kalaris Therapeutics compensation record

free company brief

This page is one person within Kalaris Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Kalaris Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Jeroen van Beek's compensation dossier · One-time report. No refunds.